Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Concentric Analgesics

Concentric Analgesics
2014 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Series B LATEST DEAL TYPE
$76M LATEST DEAL AMOUNT
5 INVESTORS
Description

Developer of novel and non-opioid therapeutics created to provide pain relief after a single local administration. The company's therapeutics targets pain at source with limited systematic exposure and reliefs without numbness or weakness during surgery, enabling medical professionals to simplify ongoing care and adherence, improves outcomes and reduces intensivity of care for osteoarthritis patients.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 101 California Street
  • Suite 1210
  • San Francisco, CA 94111
  • United States

+1 (415) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Concentric Analgesics’s full profile, request a free trial.

Concentric Analgesics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series B) 21-May-2019 $76M 000.00 00000 Completed Pre-Clinical Trials
2. Early Stage VC (Series A) 06-Dec-2016 00.000 00.000 000.00 Completed Startup
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Concentric Analgesics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series B 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A 0,000,000 00.000000 00.0 00.00 00.00 00 00.00 00.000
To view this company’s complete Cap Table, request access »

Concentric Analgesics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Cowen Healthcare Investments Venture Capital Minority 000 0000 000000 0
Jay Kern Angel (individual) Minority 000 0000 000000 0
Oracle Investment Management Hedge Fund Minority 000 0000 000000 0
Venrock Venture Capital Minority 000 0000 000000 0
California Institute for Quantitative Biosciences Accelerator/Incubator 000 0000 000000 0

Concentric Analgesics Executive Team (6)

Name Title Board
Seat
Contact
Info
Frank Bellizzi Jr. Chief Executive Officer & Board Member
John Donovan MD Co-Founder, President & Board Member
Ryan Daws Chief Financial Officer
Craig Husfeld Ph.D Co-Founder, Chief Scientific Officer & Board Member
Thomas King Executive Chairman & Board Member
You’re viewing 5 of 6 executives. Get the full list »

Concentric Analgesics Board Members (4)

Name Representing Role Since Contact
Info
Craig Husfeld Ph.D Concentric Analgesics Co-Founder, Chief Scientific Officer & Board Member 000 0000
Frank Bellizzi Jr. Concentric Analgesics Chief Executive Officer & Board Member 000 0000
John Donovan MD Concentric Analgesics Co-Founder, President & Board Member 000 0000
Thomas King Concentric Analgesics Executive Chairman & Board Member 000 0000